Your cart

Your cart is empty

x.prof 012 L-carnitine ampoules

x.prof 012 L-carnitine ampoules

SKU: T-PACX0003
Login To View Price
Tax included. Shipping calculated at checkout.

x.prof: active ingredients to design 100% customised treatments x.prof 012: metabolisation of fatty acids - pH 6.0 - 8.0 During the lipolysis process, triglycerides break down into glycerol and fatty acids. These esterified fatty acids have a limited capacity for penetration to the mitochondrion, requiring a physiological carrier. This carrier is L-carnitine, thanks to which activated fatty acids are deviated to oxidation and are not used by the body in the neoformation of triglycerides, limiting cytoplasm bioavailability of activated fatty acids. Its mechanism of action increases the efficacy of other products with lipolytic effect.

Free shipping over €30

Free Returns & Exchanges

Need help? Contact us

Secure payment

    • About x.prof 012 L-carnitine ampoules

      x.prof: active ingredients to design 100% customised treatments
      x.prof 012: metabolisation of fatty acids - pH 6.0 - 8.0

      During the lipolysis process, triglycerides break down into glycerol and fatty acids. These esterified fatty acids have a limited capacity for penetration to the mitochondrion, requiring a physiological carrier. This carrier is L-carnitine, thanks to which activated fatty acids are deviated to oxidation and are not used by the body in the neoformation of triglycerides, limiting cytoplasm bioavailability of activated fatty acids. Its mechanism of action increases the efficacy of other products with lipolytic effect.

    About x.prof 012 L-carnitine ampoules

    x.prof: active ingredients to design 100% customised treatments
    x.prof 012: metabolisation of fatty acids - pH 6.0 - 8.0

    During the lipolysis process, triglycerides break down into glycerol and fatty acids. These esterified fatty acids have a limited capacity for penetration to the mitochondrion, requiring a physiological carrier. This carrier is L-carnitine, thanks to which activated fatty acids are deviated to oxidation and are not used by the body in the neoformation of triglycerides, limiting cytoplasm bioavailability of activated fatty acids. Its mechanism of action increases the efficacy of other products with lipolytic effect.